申请人:Li Yuanchao
公开号:US20070197476A1
公开(公告)日:2007-08-23
The invention relates to triptolide derivatives of Formula (I), their pharmaceutically acceptable salts and optical isomers, Formula (I):
wherein, C5 and C6 connect with each other by a C—C single bond or double bond; when C5 and C6 are connected with C—C single bond, X and Y represents independently hydrogen, oxygen, hydroxyl, halogen, lower alkyl-oxy, lower alkyl-amino, mercapto, lower alkyl-thio, the group of formula —OCOR, —OSO
2
R or —OPO(OH)
2
, each of which is attached to C5 and C6, R represents —(CH
2
)nCO
2
Na, —(CO
2
)nCO
2
K, or —(CH
2
)nCH
3
, wherein n=1-6; Z represents hydrogen, oxygen, hydroxyl, halogen, lower alkyl-oxy, lower alkyl-amino, mercapto, lower alkyl-thio, the group of formula —OCOR, —OSO
2
R or —OPO(OH)2, each of which is linked at C14-position, R represents —(CH2)nCO2Na, —(CO
2
)nCO
2
K, or —(CH
2
)nCH
2
, wherein n=1-6; wherein, the “_” linked with X, Y, and Z represents “
” or “
”, but X and Y cannot both be hydrogen atom at the same time, the methods for preparing them and their use as antiphlogistic agent, immunosuppressive agent or therapeutic agent for other related diseases.
本发明涉及式(I)的三酰甲基衍生物、其药学上可接受的盐和光学异构体,式(I)如下:
其中,C5和C6通过C—C单键或双键连接;当C5和C6通过C—C单键连接时,X和Y分别表示氢、氧、羟基、卤素、较低的烷氧基、较低的烷基氨基、巯基、较低的烷硫基、式—OCOR、—OSO2R或—OPO(OH)2的基团,每个基团都连接在C5和C6上,其中R表示—(CH2)nCO2Na、—(CO2)nCO2K或—(CH2)nCH3,其中n为1-6;Z表示氢、氧、羟基、卤素、较低的烷氧基、较低的烷基氨基、巯基、较低的烷硫基、式—OCOR、—OSO2R或—OPO(OH)2的基团,每个基团都连接在C14位点,其中R表示—(CH2)nCO2Na、—(CO2)nCO2K或—(CH2)nCH2,其中n为1-6;其中,与X、Y和Z连接的“_”表示“”或“”,但X和Y不能同时为氢原子,本发明还涉及其制备方法以及作为抗炎剂、免疫抑制剂或治疗其他相关疾病的治疗剂的用途。